COMPETITOR_1 are the most well established competitor in our space, having recently raised a $XXXm funding round. They are also the competitor we rip out more than any other platform, as well as the competitor we most often see in successful sales cycles. As the first mover in our space, they own some of the existing enterprise contracts, but we have been successful over the last year in encouraging buyers to rip those out upon their end and replace it with V7.
COMPETITOR_1 invests heavily in sales and marketing, but their product is weaker than ours despite their greater size. This is elucidated by headcount splits, where sales, marketing and operations makes up for 60% of COMPETITOR_1 headcount, but for V7 our Engineering, Deep Learning and Customer Success/Support teams are our largest (58.6%)
In competitive analyses, we generally come out far on top in terms of performance and stability, support, and key metrics (like time per project and time per image for annotation). COMPETITOR_1 focuses heavily on selling BPO services through it’s workforce, but this stands in opposition to how most teams want to interact with these services, where the platform is underlying and there is flexibility as to how they work with services providers.
Specifically, the following features also provide significant improvements over COMPETITOR_1:
The short answer is we don’t really, we’ve lost 2 deals in FY22 to COMPETITOR_1, 1 of which was with a US Government agency, the other was with an O&G startup who were offered a significant discount to remain a COMPETITOR_1 customer, to the extent that they lost 50% of ARR from that customer.
That being said, COMPETITOR_1 have strong pre-existing relationships within Enterprise accounts, and in particular do well with US Government agencies. Whilst we almost always win against them, we also never underestimate them as they are the most well-known player, and internal feeling is that due to a relative lack of brand awareness, they win many deals that we simply do not factor into. They also provide a fully scoped Text Annotation platform which V7 does not currently support.
On deals where COMPETITOR_1 has been recorded as a competitor, and we know the company have bought a tool in the end, we’ve won 88% in FY22.
Big wins have come in healthcare (CLIENT EXAMPLES), Manufacturing (CLIENT) and High Tech (CLIENT)